California Stem Cell Agency First: Big Pharma Hook Up
BURLINGAME, Ca. – For the first time, a Big Pharma company has hooked into the $3 billion California stem cell agency, a move that the agency described as a “watershed” in its efforts to commercialize stem cell research.
The involvement of GlaxoSmithKlinecomes via a partnership with ViaCyte, Inc., of San Diego, Ca., in a clinical trial, partially finance…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.